Susquehanna International Group, LLP Biogen Inc. Call Options Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

Call Options

28 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 15, 2024	SELL	$190.52 - $236.72 $4.63 Million - $5.75 Million	-24,300 Reduced 6.54%	347,200 $80.5 Million
Q1 2024 May 07, 2024	SELL	$212.02 - $267.71 $47.2 Million - $59.6 Million	-222,700 Reduced 37.48%	371,500 $80.1 Million
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $8.84 Million - $10.6 Million	-39,700 Reduced 6.26%	594,200 $154 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $22 Million - $24.8 Million	-86,800 Reduced 12.04%	633,900 $163 Million
Q2 2023 Aug 11, 2023	SELL	$275.25 - $318.06 $47 Million - $54.4 Million	-170,900 Reduced 19.17%	720,700 $205 Million
Q1 2023 May 16, 2023	SELL	$256.56 - $292.34 $48.8 Million - $55.6 Million	-190,200 Reduced 17.58%	891,600 $248 Million
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $92.5 Million - $112 Million	-366,600 Reduced 25.31%	1,081,800 $300 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $99.6 Million - $137 Million	511,700 Added 54.63%	1,448,400 $387 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $13.3 Million - $15.8 Million	70,700 Added 8.16%	936,700 $191 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $32.1 Million - $40.4 Million	-165,500 Reduced 16.04%	866,000 $182 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $403,056 - $517,985	-1,800 Reduced 0.17%	1,031,500 $247 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $22.8 Million - $29.8 Million	-80,700 Reduced 7.24%	1,033,300 $292 Million
Q2 2021 Aug 11, 2021	BUY	$259.0 - $414.71 $89.4 Million - $143 Million	345,300 Added 44.92%	1,114,000 $386 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $109 Million - $127 Million	-446,700 Reduced 36.75%	768,700 $215 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $15.5 Million - $23.3 Million	-65,400 Reduced 5.11%	1,215,400 $298 Million
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $53.2 Million - $61.5 Million	201,100 Added 18.63%	1,280,800 $363 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $36.3 Million - $48.1 Million	-140,300 Reduced 11.5%	1,079,700 $289 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $7.34 Million - $9.31 Million	-27,300 Reduced 2.19%	1,220,000 $386 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $20.3 Million - $28.1 Million	92,400 Added 8.0%	1,247,300 $370 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $38.1 Million - $42.7 Million	175,000 Added 17.86%	1,154,900 $269 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $15 Million - $16.6 Million	-68,600 Reduced 6.54%	979,900 $229 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $1.86 Million - $2.92 Million	8,600 Added 0.83%	1,048,500 $248 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $66.6 Million - $84.3 Million	-239,100 Reduced 18.69%	1,039,900 $313 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $96.7 Million - $126 Million	329,500 Added 34.7%	1,279,000 $452 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $30.5 Million - $36.4 Million	118,500 Added 14.26%	949,500 $276 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $110 Million - $155 Million	-421,600 Reduced 33.66%	831,000 $228 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $28.1 Million - $31.4 Million	-91,200 Reduced 6.79%	1,252,600 $399 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $378 Million - $443 Million	1,343,800	1,343,800 $421 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$3.22 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$3.17 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.82 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.38 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$1.1 Billion
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $27.9B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account